SeekingAlpha · Aug 18, 2026
The Credit Market Lens: What BDC Markets Are Signaling About Private Credit Valuations
Performance within business development company (BDC) capital structures continues to diverge.
NYSE · PCR
Financial Services · Asset Management - Income
$19.71
Up+$0.00 (+0.00%)
Updated Aug 24, 2026, 7:04 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PCR closed at $19.71 after 20 trading sessions, up 3.98% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $19.64 | $19.705 | $19.63 | $19.705 | 3.96K |
| Aug 20, 2026 | $19.65 | $19.7132 | $19.65 | $19.7132 | 244.39 |
| Aug 19, 2026 | $19.7673 | $19.7673 | $19.7673 | $19.7673 | 30.39 |
| Aug 18, 2026 | $19.7315 | $19.7315 | $19.7315 | $19.7315 | 11.39 |
| Aug 17, 2026 | $19.65 | $19.7096 | $19.65 | $19.7096 | 196.64 |
| Aug 14, 2026 | $20.00 | $20.00 | $19.98 | $19.9808 | 1.26K |
| Aug 13, 2026 | $20.09 | $20.1498 | $20.07 | $20.1498 | 704.39 |
| Aug 12, 2026 | $19.84 | $19.8704 | $19.84 | $19.8704 | 240.39 |
| Aug 11, 2026 | $19.94 | $19.94 | $19.94 | $19.94 | 616.39 |
| Aug 10, 2026 | $19.90 | $19.90 | $19.90 | $19.90 | 99.39 |
| Aug 7, 2026 | $19.9763 | $19.9763 | $19.9763 | $19.9763 | 36.39 |
| Aug 6, 2026 | $19.61 | $19.61 | $19.52 | $19.555 | 2.24K |
| Aug 5, 2026 | $19.0341 | $19.0341 | $19.0341 | $19.0341 | 297.39 |
| Aug 4, 2026 | $19.3108 | $19.3108 | $19.3108 | $19.3108 | 72.39 |
| Aug 3, 2026 | $19.0395 | $19.09 | $19.0395 | $19.0762 | 528.89 |
| Jul 31, 2026 | $18.685 | $18.7354 | $18.59 | $18.7354 | 5.67K |
| Jul 30, 2026 | $18.7393 | $18.7393 | $18.7393 | $18.7393 | 17.39 |
| Jul 29, 2026 | $18.80 | $18.83 | $18.725 | $18.725 | 729.39 |
| Jul 28, 2026 | $18.84 | $19.02 | $18.84 | $18.9727 | 260.39 |
| Jul 27, 2026 | $18.95 | $18.95 | $18.95 | $18.95 | 36.39 |
The latest Smart Investors Daily articles mentioning PCR.
PCR research
Company profile and research snapshot.
PCR is an actively managed ETF employing two primary strategies: private credit exposure via index tracking, and a long/short equity hedge. The bulk of the assets are invested in publicly-traded business development companies and closed-end funds focused on private credit, as determined by an index. A proprietary scoring methodology for volatility and yield is used to select index holdings, favoring those with lower volatility and higher yield. Positions are weighted by trading volume, and the fund may hold larger allocations in fewer issuers. The index is reconstituted and rebalanced semi-annually. The credit hedging strategy uses total return swaps to go long on quality equities and short junk equities. The fund may take temporary defensive positions during adverse market conditions.
Consensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Aug 18, 2026
Performance within business development company (BDC) capital structures continues to diverge.
SeekingAlpha · Aug 10, 2026
U.S. fixed income and equity markets saw solid gains last week as a surprisingly weak July employment report sparked a rally in Treasuries.
SeekingAlpha · Aug 10, 2026
Analysts are raising earnings forecasts even as long-term government bond yields rise. These aren't contradictory signals. Both are consistent with the structural changes reshaping markets.
SeekingAlpha · Aug 5, 2026
In this article, we explore five key trends shaping private creditâs outlook and why transparency and standardization will be the bedrock of its next era. Read more here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning PCR.